| Health Canada | news releases
Health Canada has launched a three-year, $300,000 micro-grant fund to support community-based initiatives that address the psychological and social aspects of palliative care.
| Health Canada | news releases
Today, the Government of Canada announced the final amendments to the Patented Medicines Regulations. The most significant reforms to the regulations since their introduction in 1987, these amendments will give the Patented Medicine Prices Review Board (PMPRB) the tools to protect Canadians from excessive prices and make patented medicines more affordable.
| Health Canada | media advisories
Health Canada officials will provide an update on important steps toward National Pharmacare
| Health Canada | news releases
Health Canada is providing the University of Calgary’s Department of Family Medicine with approximately $713,000 in funding over three years to develop a telehealth model to deliver opioid agonist therapy in remote areas of Alberta, and in primary care settings serving Indigenous populations.
| Health Canada | news releases
The Honourable Ginette Petitpas Taylor, Minister of Health, toured Sudbury’s KICX for Kids Club House treatment facility at Health Sciences North Hospital and provided pediatricians, parents and children’s health advocates with an update on Health Canada’s activities to support better access to pediatric treatments.
| Health Canada | statements
July 24 is International Self-Care Day—an opportunity to raise awareness about self-care and the important role it plays in leading a healthy lifestyle.
| Health Canada | media advisories
The Honourable Ginette Petitpas Taylor, Canada’s Minister of Health, will be in Sudbury to highlight recent Government of Canada initiatives related to paediatric drugs
| Health Canada | media advisories
The Honourable Ginette Petitpas Taylor, Canada’s Minister of Health, will be in Sault Ste. Marie to participate in a roundtable working session to discuss Canada’s opioid crisis.
| Health Canada | news releases
Canadians want access to the latest treatments for themselves, their family and their friends— especially for diseases and conditions where limited options are available. Health Canada works every day to give Canadians timely, safe and secure access to drugs and medical devices. Over the last four months, Health Canada has approved 16 new drugs and medical devices to treat a range of health issues (list available below).
| Health Canada | statements
Pfizer Canada is reporting that a shortage of its 0.3 mg format EpiPen auto-injector may lead to temporary supply constraints in the coming months. EpiPen Jr (0.15 mg) is not affected by this shortage.
